REVATRUTIDE RESEARCH PEPTIDE

REVATRUTIDE RESEARCH PEPTIDE

Retatrutide, also known as LY3437943, is a synthetic modified peptide commonly studied in laboratory research involving GLP-1 receptor, GIP receptor, and glucagon receptor signaling. It is frequently referenced as a triple hormone receptor agonist in research literature and is evaluated in models involving metabolic-response pathways, receptor-binding activity, metabolic-signaling systems, peptide stability, and structure-activity relationships. Structurally, retatrutide is a lipidated peptide with amino acid modifications designed for extended pharmacokinetic research.

This product is intended strictly for laboratory research use only. It is not for human consumption, clinical use, therapeutic use, diagnostic use, veterinary use, or cosmetic application.

Technical Data

Product Name: Retatrutide
Synonyms: LY3437943
Peptide Type: Synthetic modified peptide
Peptide Length: 39 amino acids
Receptor Research Focus: GLP-1R / GIPR / GCGR
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: 4731.34 g/mol
CAS Number: 2381089-83-2
PubChem CID: 497620843
Appearance: Lyophilized powder
Solubility: Commonly reported as soluble in water and aqueous buffers
Storage: Store sealed, dry, protected from light, and under appropriate laboratory-controlled conditions